ETFs & Funds
seems to have found its pre-earnings release range between 19.85 and 20.00 after the FDA report.
Add a reply...
Latest StockTalks »
people get IPXL breaking news and analysis by email alert.
Get email alerts on IPXL »
Impax Laboratories, Inc.
Get latest price
From other sites
Oversold Conditions For Impax Laboratories (IPXL)
at Nasdaq.com (Jun 21, 2016)
Goldman Initiates Impax Labs With Sell Rating, $33 Target
at Benzinga (Jun 6, 2016)
Commit To Buy Impax Laboratories At $30, Earn 12% Annualized Using Options
at Nasdaq.com (Jun 2, 2016)
Is a Surprise Coming for Impax Laboratories (IPXL) This Earnings Season?
at Zacks.com (May 9, 2016)
Impax Laboratories Enters Oversold Territory (IPXL)
at Nasdaq.com (May 6, 2016)